April 23-27, 2017 12:00 PM ET

San Diego, CA, Sheraton San Diego Hotel and Marina United States

Presentation: Biomarker Discovery and Development of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor
Meeting: 8th Annual Inflammation Inhibitors: Small Molecule Approaches for Oral-based Therapeutics
Presenter: Larry Mattheakis, Ph.D., Vice President, Biology, Protagonist Therapeutics 

Date and Time: 10:35 am PT, Monday April 24

Presentation: Discovery & Development of PTG-100, an Oral Peptide Antagonist of α4β7 Integrin, for the Treatment of Inflammatory Bowel Disease
Meeting: 5th Annual Macrocyclics and Constrained Peptides: Bigger, Better and Still Oral Small Molecules
Presenter: Ashok Bandari, Ph.D., Vice President, Chemistry, Protagonist Therapeutics 

Date and Time: 2:20 PM PT, Wednesday April 26